Cargando…
SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of European Society for Medical Oncology.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527840/ https://www.ncbi.nlm.nih.gov/pubmed/34687893 http://dx.doi.org/10.1016/j.annonc.2021.10.004 |
_version_ | 1784586151555760128 |
---|---|
author | Figueiredo, J.C. Ihenacho, U. Merin, N.M. Hamid, O. Darrah, J. Gong, J. Paquette, R. Mita, A.C. Vescio, R. Mehmi, I. Basho, R. Salvy, S.J. Shirazipour, C.H. Caceres, N. Finster, L.J. Coleman, B. Arnow, H.U. Florindez, L. Sobhani, K. Prostko, J.C. Frias, E.C. Stewart, J.L. Merchant, A. Reckamp, K.L. |
author_facet | Figueiredo, J.C. Ihenacho, U. Merin, N.M. Hamid, O. Darrah, J. Gong, J. Paquette, R. Mita, A.C. Vescio, R. Mehmi, I. Basho, R. Salvy, S.J. Shirazipour, C.H. Caceres, N. Finster, L.J. Coleman, B. Arnow, H.U. Florindez, L. Sobhani, K. Prostko, J.C. Frias, E.C. Stewart, J.L. Merchant, A. Reckamp, K.L. |
author_sort | Figueiredo, J.C. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8527840 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Published by Elsevier Ltd on behalf of European Society for Medical Oncology. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85278402021-10-21 SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment Figueiredo, J.C. Ihenacho, U. Merin, N.M. Hamid, O. Darrah, J. Gong, J. Paquette, R. Mita, A.C. Vescio, R. Mehmi, I. Basho, R. Salvy, S.J. Shirazipour, C.H. Caceres, N. Finster, L.J. Coleman, B. Arnow, H.U. Florindez, L. Sobhani, K. Prostko, J.C. Frias, E.C. Stewart, J.L. Merchant, A. Reckamp, K.L. Ann Oncol Letter to the Editor Published by Elsevier Ltd on behalf of European Society for Medical Oncology. 2022-01 2021-10-20 /pmc/articles/PMC8527840/ /pubmed/34687893 http://dx.doi.org/10.1016/j.annonc.2021.10.004 Text en © 2021 Published by Elsevier Ltd on behalf of European Society for Medical Oncology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Figueiredo, J.C. Ihenacho, U. Merin, N.M. Hamid, O. Darrah, J. Gong, J. Paquette, R. Mita, A.C. Vescio, R. Mehmi, I. Basho, R. Salvy, S.J. Shirazipour, C.H. Caceres, N. Finster, L.J. Coleman, B. Arnow, H.U. Florindez, L. Sobhani, K. Prostko, J.C. Frias, E.C. Stewart, J.L. Merchant, A. Reckamp, K.L. SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment |
title | SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment |
title_full | SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment |
title_fullStr | SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment |
title_full_unstemmed | SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment |
title_short | SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment |
title_sort | sars-cov-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527840/ https://www.ncbi.nlm.nih.gov/pubmed/34687893 http://dx.doi.org/10.1016/j.annonc.2021.10.004 |
work_keys_str_mv | AT figueiredojc sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT ihenachou sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT merinnm sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT hamido sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT darrahj sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT gongj sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT paquetter sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT mitaac sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT vescior sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT mehmii sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT bashor sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT salvysj sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT shirazipourch sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT caceresn sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT finsterlj sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT colemanb sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT arnowhu sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT florindezl sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT sobhanik sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT prostkojc sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT friasec sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT stewartjl sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT merchanta sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment AT reckampkl sarscov2vaccineuptakeperspectivesandadversereactionsfollowingvaccinationinpatientswithcancerundergoingtreatment |